Vertex Pharmaceuticals Stock Price

Vertex Pharmaceuticals, VR

Should You Buy Vertex Pharmaceuticals Stock Hand Over Fist Before Jan. 30?

Vertex Pharmaceuticals ( VRTX 3.06%) might be one of those special cases. Should you buy Vertex stock hand over fist before Jan. 30? What's so special about Jan. 30 for Vertex? It's the PDUFA action date set by the U.S. Food and Drug Administration (FDA) for making an approval decision on suzetrigine in treating acute pain.

Hosted on MSN · 4d

Here is What to Know Beyond Why Vertex Pharmaceuticals Incorporated (VRTX) is a Trending Stock

Vertex Pharmaceuticals (VRTX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.

ETF Daily News · 8d

Wells Fargo & Company Has Lowered Expectations for Vertex Pharmaceuticals (NASDAQ:VRTX) Stock Price

Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) had its price objective cut by Wells Fargo & Company from $555.00 to $460.00 in a report issued on Friday,Benzinga reports. The brokerage currently has an “overweight” rating on the pharmaceutical company’s stock.

MarketWatch · 3d

Vertex Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors

Vertex Pharmaceuticals Inc. closed 19.80% below its 52-week high of $519.88, which the company reached on November 8th.

Yahoo Finance2d

Vertex Pharmaceuticals Incorporated (VRTX)

David Jagielski (Eli Lilly): It may look as though Eli Lilly's stock has peaked given its recent slide, but there's still a lot more room for it to run higher. Vertex Pharmaceuticals (NASDAQ ...

Vertex Pharmaceuticals: Strategic Advancements and Promising Pipeline Drive Buy Rating

Analyst Evan Seigerman of BMO Capital maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report), retaining the price target of ...

How Is The Market Feeling About Vertex Pharmaceuticals?

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling ...

Nasdaq18d

Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know

Vertex Pharmaceuticals (VRTX ... correlation between trends in earnings estimate revisions and near-term stock price movements. Vertex is expected to post earnings of $4 per share for the ...

Vertex Pharmaceuticals: Strong Future Potential with Key Drug Launches and Underappreciated Opportunities

Jefferies analyst Michael Yee has maintained their bullish stance on VRTX stock, giving a Buy rating today.Stay Ahead of the Market:Discover ...

Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day

Vertex Pharmaceuticals Inc. closed 18.83% below its 52-week high of $519.88, which the company achieved on November 8th.

Vertex Pharmaceuticals Sets Sight on Expanding Portfolio with Alyftrek Approval, Pain Treatment Progress, and Diabetes Trials

Vertex secures FDA approval for ALYFTREK and expands TRIKAFTA use, advances diabetes and kidney disease therapies, and ...

Vertex Pharmaceuticals: Balancing Growth Prospects and Uncertainties with a Hold Rating

Morgan Stanley analyst Terence Flynn maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research Report) today and set a price target ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results